Stock DNA
Financial Conglomerates
CAD 2 Million ()
NA (Loss Making)
NA
0.00%
-999,999.00
338.98%
-1.81
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2024)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
147.62%
0%
147.62%
6 Months
73.33%
0%
73.33%
1 Year
36.84%
0%
36.84%
2 Years
278.18%
0%
278.18%
3 Years
-16.8%
0%
-16.8%
4 Years
-16.8%
0%
-16.8%
5 Years
0%
0%
0.0%
GHP Noetic Science-Psychedelic Pharma, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
10.45%
EBIT to Interest (avg)
-1.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.81
EV to EBIT
-0.93
EV to EBITDA
-0.94
EV to Capital Employed
3.58
EV to Sales
2.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-384.17%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'24 - YoY
Jun'24
Jun'23
Change(%)
Net Sales
0.60
0.00
Operating Profit (PBDIT) excl Other Income
-0.60
-0.00
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.60
-0.00
Operating Profit Margin (Excl OI)
-956.20%
0.00%
-95.62%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2024 is 0.00% vs 0.00% in Jun 2023
Consolidated Net Profit
YoY Growth in quarter ended Jun 2024 is 0.00% vs 0.00% in Jun 2023
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.10
-0.10
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.10
-0.10
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is 0.00% vs 66.67% in Dec 2021
About GHP Noetic Science-Psychedelic Pharma, Inc. 
GHP Noetic Science-Psychedelic Pharma, Inc.
Financial Conglomerates
GHP Noetic Science-Psychedelic Pharma Inc. is a Canada-based capital pool company. The Company is focused on the identification and evaluation of assets or businesses with a view to completing a Qualifying Transaction.






